| 000 | 01724 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516220733.0 | ||
| 264 | 0 | _c20141121 | |
| 008 | 201411s 0 0 eng d | ||
| 022 | _a1432-0584 | ||
| 024 | 7 |
_a10.1007/s00277-014-2138-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSalah-Eldin, Manal A | |
| 245 | 0 | 0 |
_aClinical outcome of HCV-positive patients with diffuse large B-cell lymphoma treated with rituximab-based chemotherapy. _h[electronic resource] |
| 260 |
_bAnnals of hematology _cNov 2014 |
||
| 300 |
_a1903-11 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aHepatitis C _xdiagnosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, Large B-Cell, Diffuse _xdiagnosis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPrednisone _xadministration & dosage |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 |
_aSurvival Rate _xtrends |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aEbrahim, Mohamed A | |
| 700 | 1 | _aEl-Sadda, Wael | |
| 773 | 0 |
_tAnnals of hematology _gvol. 93 _gno. 11 _gp. 1903-11 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00277-014-2138-5 _zAvailable from publisher's website |
| 999 |
_c23939513 _d23939513 |
||